Decision Resources Group has released the Biosimilar Advisory Service: Corporate Strategies report on partnership activity in the biosimilar space, which shows a 34% increase in 2013 compared with 2012. According to the report, this increase was driven by the need for companies to augment internal capabilities with market players in order to enter the biosimilar space. The high number of partnerships is attributed to the complexity of bringing a biosimilar from development to market.   According...